Biopharma companies and doctors sue over marijuana reclassification; several states sue over canceled offshore leases

Biopharmaceutical companies and doctors have sued the Trump administration, challenging its decision to reclassify marijuana. The plaintiffs include biopharmaceutical companies and medical professionals. The lawsuit directly targets the change in marijuana’s legal status.

Separately, several state governments have sued the administration, challenging its decision to cancel offshore oil and gas leases. The plaintiffs include multiple state governments. The lawsuit disputes the legal basis for the federal government’s lease cancellations.

Both cases are legal challenges to policy decisions by the administration. Details of the relevant lawsuits and their filings were reported in news on 6month 2day. Both lawsuits are currently awaiting court hearings.

The specific claims in the marijuana reclassification lawsuit and the detailed list of plaintiffs in the offshore leasing lawsuit can be found in the court filings. Each filing includes a court case number and filing date. If the original court filings are made public, their details will need to be reviewed.

These lawsuits show that legal disputes arising from changes in federal policy are continuing. The court’s rulings directly affect the application of relevant regulations and business activities. The scope of the impact will become clearer through future court decisions and the filed court documents.